- Home
- » Tags
- » Invasive candidiasis
Top View
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Peter G
- Burden of Serious Fungal Infections in Jordan
- Genetics Susceptibility to Infectious Diseases
- Estimating the Burden of Invasive and Serious Fungal Disease in the United Kingdom
- Diagnosis of Invasive Fungal Infections – Current Limitations of Classical and New Diagnostic Methods
- Burden of Serious Fungal Infections in Mexico
- Risk of Invasive Candidiasis with Prolonged Duration of ICU Stay: a Systematic Review and Meta-Analysis
- A Review on Candidiasis: Types and Medications
- Invasive Fungal Infections in Persons Living with HIV in an Amazonian Context: French Guiana, 2009–2019
- An Overview of Invasive Candidiasis, Aspergillosis, Cryptococcosis, and Pneumocystis Pneumonia
- Estimated Burden of Serious Human Fungal Diseases in Turkey
- 1 Candidiasis
- Antifungal Susceptibilities of Candida, Cryptococcus Neoformans
- Update on Management of Invasive Candidiasis
- 56.Jnanamba P, Krishan Pal Singh, Raghavendra
- Candida Albicans—The Virulence Factors and Clinical Manifestations of Infection
- Examples of Fungal Infections
- MODULE 1: Epidemiology and Risk Factors for Invasive Fungal Infections
- How to Treat Fungal Infections in ICU Patients Dimitrios K Matthaiou*, Theodora Christodoulopoulou and George Dimopoulos
- INVASIVE CANDIDIASIS (CAGTA) IFA Igg (Ref
- Guide to Infection Control in the Hospital
- Clinical and Microbiological Diagnosis of Oral Candidiasis
- An Estimate of the Burden of Fungal Disease in Norway
- Candida Albicans
- Fosmanogepix: a Review of the First-In-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections
- An Approach to Etiology, Diagnosis and Management of Different Types of Candidiasis
- Mucormycosis: Pathogenesis and Pathology
- Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants
- Candidiasis.Pdf
- Clinical Manifestations of Candidiasis: Beyond Candida Albicans
- COVID-19-Associated Candidiasis (CAC): an Underestimated Complication in the Absence of Immunological Predispositions?
- Review: Hidden Killers: Human Fungal Infections
- Burden of Serious Fungal Infections in the Czech Republic
- Epidemiology and Burden of Invasive Fungal Infections in the Countries Of
- Candida: the Unfriendly Yeast NHS.UK
- Candida Species
- Patient Susceptibility to Candidiasis—A Potential for Adjunctive Immunotherapy
- De-Feet the Yeast 1 De-Feet the Yeast Tori Robinson
- Diagnosis and Treatment of Candidaemia and Aspergillosis
- Epidemiology of Hospitalizations Associated with Invasive Candidiasis, United States, 2002–20121 Sara Strollo,2 Michail S
- Introduction - Fungal Disease in Britain and the United States 1850–2000 - NCBI Bookshelf
- Treatment of Invasive Candidiasis: a Narrative Review
- High Mortality Co-Infections of COVID-19 Patients: Mucormycosis and Other Fungal Infections
- Treatment of Invasive Candida and Invasive Aspergillus Infections In
- Nature of the Yeast! Therapeutic Approach to Common Invasive Yeast Infections
- Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts
- 7 Candidiasis DH Dockrell1,2, D O’Shea 1,2, JD Cartledge3, AR Freedman4
- Uk-Aspergillosis.Pdf 1